Velindre University NHS Trust has proudly received the Digital Inclusion Charter Accreditation from Digital Communities Wales (DCW), marking a significant milestone in its commitment to digital equity and innovation.
Velindre Cancer Service has treated our first patient with Tebentafusp – a novel type of immunotherapy known as a T-cell engager.
On Friday 25 July, we welcomed 11 Young Ambassadors, their families and their friends to construct and paint 3 new flower bed planters for Velindre Cancer Centre.
Velindre Cancer Service has commenced a new service for patients with neuroendocrine tumours (NETs), offering local treatment with a specialist form of targeted radionuclide therapy.
On July 31, we say a fond farewell to our Chair, Professor Donna Mead OBE, and Vice-Chair, Stephen Harries. Their dedication to the improvement of public service has left an indelible mark on Velindre University NHS Trust.
We are delighted to share that as of June 2025, Velindre @ Nevill Hall Radiotherapy Unit is open and operational - helping us to make high-quality cancer care more accessible to South East Wales.
The Cabinet Secretary for Health and Social Care has today announced that Sara Moseley will take up the role of Chair of Velindre University NHS Trust from 1 September 2025.